We’re pleased to announce that CredibleMeds was recently cited in two major scientific publications of practice guidelines for cardiologists.
FDA offers BeSafeRX to raise awareness of the dangers of buying prescription medicines from fake online pharmacies
FDA BeSafeRx is a national campaign to raise awareness of the dangers of buying prescription medicines from fake online pharmacies. This campaign provides the resources to help consumers.
Study of Danish National Healthcare System Uses CredibleMeds QTdrugs List to Assess Risk Factors for Sudden Cardiac Death
The CredibleMeds online QTdrugs list was recently applied in a study carried out in Denmark to evaluate the association between use of medications on sudden cardiac death (SCD). With a sharp increase in the number of prescribed drugs to the general population over the past decade, researchers sought to examine whether there is a significant correlation between multiple prescription drug use and SCD.
AZCERT’s Board of Directors Gains Experience and Expertise with the Addition of Two New Board Members
AZCERT, sponsor of CredibleMeds, is delighted to announce the addition of two new members to our Board of Directors. Doctors Jim Galloway and Jim Tisdale bring talent and broad expertise to the Board of AZCERT and CredibleMeds. For more information on the extraordinary stories of our newest leaders.
P&T Journal’s Pharmacovigilance Column Features CredibleMeds in a Recent Article on Drug-Induced QT Prolongation and Torsades De Pointes
We’re excited to announce that CredibleMeds was recently featured as a trusted, informative resource in a recent article published in P&T Community’s Pharmacovigilance Forum. The article focuses on the many common medicines that may increase the risk of drug-induced QT Prolongation and Torsades de Pointes arrhythmia